Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples